Evidence mapPaperPMID 37803429Full record

ArticleBreast cancer research : BCR2023

Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary gland.

Bradley A Krisanits, Reid Schuster, Jaime Randise, Lourdes M Nogueira, Jackson T Lane, Gowtami A Panguluri, Hong Li, Kristi Helke, Maria C Cuitiño, Christopher Koivisto and 5 more

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. The Anti-AGEing and RAGEing Potential of Isothiocyanates.Molecules (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bradley A KrisanitsDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
Reid SchusterDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
Jaime RandiseDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
Lourdes M NogueiraDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
Jackson T LaneDepartment of Surgery and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Gowtami A PanguluriDepartment of Surgery and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Hong LiDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Kristi HelkeDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
Maria C CuitiñoDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Christopher KoivistoDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Laura SpruillDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
Michael C OstrowskiDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Steven M AndersonDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
David P TurnerDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA. david.turner1@vcuhealth.org.
Victoria J FindlayDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA. victoria.findlay@vcuhealth.org.

Funding

University of Colorado Cancer Center Support GrantP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · 1988 to 2025
$33.7M
Shared Resource ManagementP30CA093373 · UNIVERSITY OF CALIFORNIA DAVIS · 2002 to 2025
$10.6M
Translational Science Laboratory Shared ResourceP30CA138313 · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2025 to 2025
$2.4M
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor StromaR01CA259415 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · 2024 to 2025
$820k
Lifestyle associated reactive metabolites and their negative impact on breast cancer riskR01CA245143 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Victoria Jane Findlay, David Paul Turner · 2023 to 2023
$398k
NCI NIH HHS P30 CA046934NCI NIH HHS P30 CA093373NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA245143NCI NIH HHS R01 CA259415NCI NIH HHS R21 CA258139
6 · The paper itself

Abstract

backgroundAdvanced glycation end products (AGEs) are reactive metabolites intrinsically linked with modern dietary patterns. Processed foods, and those high in sugar, protein and fat, often contain high levels of AGEs. Increased AGE levels are associated with increased breast cancer risk, however their significance has been largely overlooked due to a lack of direct cause-and-effect relationship.

methodsTo address this knowledge gap, FVB/n mice were fed regular, low AGE, and high AGE diets from 3 weeks of age and mammary glands harvested during puberty (7 weeks) or adulthood (12 weeks and 7 months) to determine the effects upon mammary gland development. At endpoint mammary glands were harvested and assessed histologically (n ≥ 4). Immunohistochemistry and immunofluorescence were used to assess cellular proliferation and stromal fibroblast and macrophage recruitment. The Kruskal-Wallis test were used to compare continuous outcomes among groups. Mammary epithelial cell migration and invasion in response to AGE-mediated fibroblast activation was determined in two-compartment co-culture models. In vitro experiments were performed in triplicate. The nonparametric Wilcoxon rank sum test was used to compare differences between groups.

resultsHistological analysis revealed the high AGE diet delayed ductal elongation, increased primary branching, as well as increased terminal end bud number and size. The high AGE diet also led to increased recruitment and proliferation of stromal cells to abnormal structures that persisted into adulthood. Atypical hyperplasia was observed in the high AGE fed mice. Ex vivo fibroblasts from mice fed dietary-AGEs retain an activated phenotype and promoted epithelial migration and invasion of non-transformed immortalized and tumor-derived mammary epithelial cells. Mechanistically, we found that the receptor for AGE (RAGE) is required for AGE-mediated increases in epithelial cell migration and invasion.

conclusionsWe observed a disruption in mammary gland development when mice were fed a diet high in AGEs. Further, both epithelial and stromal cell populations were impacted by the high AGE diet in the mammary gland. Educational, interventional, and pharmacological strategies to reduce AGEs associated with diet may be viewed as novel disease preventive and/or therapeutic initiatives during puberty.

Indexed as

Dietary Advanced Glycation End ProductsSexual MaturationAnimalsCell ProliferationHyperplasiaMammary Glands, AnimalMiceMorphogenesisDietary Advanced Glycation End ProductsAdvanced glycation end productsDietMammary gland developmentMicroenvironmentPubertyRAGE

Identifiers

PMID37803429
PMCPMC10559657

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.